Posts

Recordati licenses Ionis drug

Shionogi Receives $119M BARDA Award to Establish US Antibiotic Manufacturing Plant

NIH and HHS Cancel Major mRNA Vaccine Research Funding, Citing Lack of Public Trust

Vaxart Seeks Clarity After BARDA Suspends Funding for Oral COVID-19 Vaccine Project Again

HHS ousts MAHA implementation lead amid rushed cancellations of $500M in mRNA vaccine contracts

HHS Cancels $500 Million in BARDA-Funded mRNA Vaccine Contracts Amid Strategic Shift

HHS Ends BARDA Funding for Future mRNA Vaccine Development, Citing Efficacy Concerns

HHS lifts stop work order on Vaxart's COVID-19 trial, continues funding for the 10,000-participant study

HHS Terminates Funding for GeoVax’s Next-Generation COVID-19 Vaccine: Impacts and Developments